Sun Pharma said its profit could be hurt due to "certain expenses/charges arising out of integration as well as remedial actions."
The move impacts multinational drugmakers, like Abbott Laboratories and GlaxoSmithKline, and a number of local firms, including Lupin, Cadila Healthcare and, all of whom sell drugs added to the li...
The policy document, welcomed by many in the industry despite concerns over a lack of detail, also outlines plans to boost local manufacturing and reduce reliance on imports.
More than a third of India's 2.1 million HIV/AIDS patients depend on getting their daily antiretrovirals for free from state-run distribution centres.
"The fact that you actually come for surgery or medical treatment would be an incidental part of the experience," ABV Group Chief Executive Advet Bhambhani told Reuters.
Mahindra and Mahindra said on Thursday it would buy a 33 per cent voting stake in the agricultural machinery-making unit of Mitsubishi Heavy Industries for $25 million.
The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.
Ranbaxy filed "grossly inadequate" applications seeking approval for its drugs and deceived the FDA into granting approvals and giving the company market exclusivity.
Almost two-thirds of the drug combinations widely sold in India to fight pain, depression, and psychotic conditions lack the necessary regulatory approvals, a study published on Tuesday shows.
Investment bankers say on the radar are US and European companies that develop biosimilars - cheaper copies of biotech drugs.